Beyond structure and activity: targeting class A carbapenemases with monocyclic and bicyclic boronic acids to counter antimicrobial resistance
Top Cited Papers
- 25 February 2026
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (8) , 1595-1599
Abstract
Bicyclic boronic acids inhibit SME-1 carbapenemase via a unique π–π stacking with His105 and covalent interaction with Ser70.Keywords
Funding Information
- Indian Council of Medical Research (EM/Dev/IG/20/0773/202)
- Indian Council of Medical Research (Intramural/CD/2023/IIRP2023-0000072)
- Board of Research in Nuclear Sciences (54/14/03/2023-BRNS)
This publication has 9 references indexed in Scilit:
- First report of SME-carbapenemase–producing Serratia marcescens in FranceJournal of Antimicrobial Chemotherapy, 2025
- Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D EnzymesJournal of Medicinal Chemistry, 2021
- Geographical and temporal clustering of OXA-48-producing Escherichia coli ST410 causing community-onset urinary tract infection in Christchurch, New ZealandJournal of Antimicrobial Chemotherapy, 2018
- Structural and Functional Aspects of Class A CarbapenemasesCurrent Drug Targets, 2016
- Serratia marcescens harbouring SME-type class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1Journal of Antimicrobial Chemotherapy, 2014
- SME Carbepenemases: An Emerging Threat?American Journal of Clinical Pathology, 2012
- Novel Insights into the Mode of Inhibition of Class A SHV-1 β-Lactamases Revealed by Boronic Acid Transition State InhibitorsAntimicrobial Agents and Chemotherapy, 2011
- Revised Ambler classification of β-lactamasesJournal of Antimicrobial Chemotherapy, 2005
- β-lactamase inhibitors. The inhibition of serine β-lactamases by specific boronic acidsBiochemical Journal, 1988